Advertisement

Search Results for "Corporate Headquarters For Covance Inc"

02:26 EDT 22nd May 2013 | BioPortfolio

Original Source: Covance

Covance (NYSE: CVD), with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1 billion, global operations in 18 countries, and more than 7,000 employees worldwide.Worldwide, Covance helps pharmaceutical and biotech companies of all sizes fulfill their research and development, clinical trial, regulatory and marketing-support needs.

Matching Channels

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

College Hill - international business communications consultancy

College Hill is a growing international business communications consultancy with offices in Europe, China, India, South Africa and the United States. College Hill's wide range of complementar...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

O2PR

O2PR is a specialist PR and communications consultancy providing bespoke services to public and private sector organisations operating in the fields of science, engineering and technology. The de...

Matching News

Covance Inc. Invites You to Join the Webcast of Its First Quarter 2013 Financial Results Conference Call

PRINCETON, N.J., April 3, 2013 /PRNewswire/ -- In conjunction with its first quarter 2013 earnings release (expected to be issued after market close on May 1, 2013), Covance Inc. (NYSE: CVD) is p...

Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2012 Financial Results Conference Call

PRINCETON, N.J., Oct. 5, 2012 /PRNewswire/ -- In conjunction with its third quarter 2012 earnings release (expected to be issued after market close on November 5, 2012), Covance Inc. (NYSE: CVD)...

Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2012 Financial Results Conference Call

PRINCETON, N.J., June 25, 2012 /PRNewswire/ -- In conjunction with its second quarter 2012 earnings release (expected to be issued after market close on July 25, 2012), Covance Inc. (NYSE: CVD) i...

Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2012 Financial Results Conference Call

PRINCETON, N.J., Jan. 3, 2013 /PRNewswire/ -- In conjunction with its fourth quarter 2012 earnings release (expected to be issued after market close on January 24, 2013), Covance Inc. (NYSE: CVD)...

Layne Christensen Consolidating Headquarters and Leadership to New Corporate Headquarters

MISSION WOODS, Kan., Dec. 6, 2012 (GLOBE NEWSWIRE) -- Layne Christensen Company (Nasdaq:LAYN) ("Layne" or the "Company") announced today that its Board of Directors has approved the relocation of the...

Bayer, Covance Enter Strategic Partnership

Will leverage Covance's clinical development experience and services

Bayer CRO consolidation sets up Covance for rise in revenue

Bayer could spend up to 50 per cent more with Covance after it cuts ties with its other late phase CRO partner.

GNS, Covance to develop models to predict development success

Data analytics company GNS Healthcare Inc. (Cambridge, Mass.) and CRO Covance Inc. (NYSE:CVD) partnered to develop computer models to predict the likelihood of a therapy's development success based on...

Matching PubMed Articles

Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults.

Pneumococcal vaccines based on conserved protein antigens have the potential to offer expanded protection against Streptococcus pneumoniae.

Teaching cross-cultural aspects of mourning: A Hindu perspective on death and dying.

The value of certification and the CIC credential.

The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy.

BACKGROUND: The American Red Cross began preferentially distributing plasma from male donors in 2007 and subsequently observed an 80% decrease in reported cases of transfusion-related acute lung injur...

Asbestos is still with us: repeat call for a universal ban.

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement